Maxcyte (MXCT) Cash from Investing Activities (2020 - 2026)

Maxcyte (MXCT) has 7 years of Cash from Investing Activities data on file, last reported at $2.7 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 72.13% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $19.1 million, a 38.22% decrease from a year earlier, with the FY2025 full-year figure at $25.9 million, up 274.13% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $2.7 million, down from $9.7 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for MXCT reached as high as $194.8 million in Q1 2022 and fell as low as -$131.9 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged $3.9 million across 5 years, with a median of $2.8 million in 2023.
• On a YoY basis, Cash from Investing Activities climbed as much as 1141.41% in 2022 and fell as far as 257.12% in 2022.
• Year by year, Cash from Investing Activities stood at -$27.1 million in 2022, then surged by 84.72% to -$4.1 million in 2023, then jumped by 59.77% to -$1.7 million in 2024, then soared by 681.14% to $9.7 million in 2025, then slumped by 72.55% to $2.7 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $2.7 million in Q1 2026, $9.7 million in Q4 2025, and $5.2 million in Q3 2025.